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Background
Diabetes mellitus (DM) during pregnancies, maternal dia-
betes, is recognized as a hostile environment for the 
development of the embryo and fetoplacental circulation. 
It can result in foetal morbidity and, later, an increased 
risk of cardiovascular diseases.1,2 Maternal diabetes can 
be divided into pregestational and gestational diabetes 
mellitus (GDM). Pregestational DM refers to women pre-
viously diagnosed with either type 1 or type 2 diabetes 
mellitus (T1DM and T2DM, respectively) prior to the 
pregnancies. GDM, however, is defined as any degree of 
glucose intolerance with the onset of pregnancy. Optimal 
utero-placental and feto-placental blood flow, that is, effi-
cient placental perfusion throughout gestation, is essential 
for oxygen and nutrient transport to the developing foetus. 
Human placenta at term from both pregestational type 1 
and gestational diabetes have been shown to exhibit 
histopathological changes such as placental immaturity 
and abnormalities in both foetal and maternal placental 
vasculature.3–8 While placentae from pregnancies compli-
cated by T1DM exhibited increased angiogenesis and 
leaky blood vessels with loss of key junctional adhesion 
molecules, GDM placentae were also found to show less 
severe, but still statistically significant downregulation of 
endothelial cell–cell junctional molecules.5,6
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Abstract
Background: There is clinical and experimental evidence for altered adenosine signalling in the fetoplacental circulation 
in pregnancies complicated by diabetes, leading to adenosine accumulation in the placenta. However, the consequence 
for fetoplacental vasocontractility is unclear. This study examined contractility to adenosine of chorionic vessels from 
type 1 diabetes mellitus, gestational diabetes mellitus and normal pregnancies.
Methods: Chorionic arteries and veins were isolated from human placenta from normal, gestational diabetes mellitus 
and type 1 diabetes mellitus pregnancies. Isometric tension recording measured responses to adenosine and the 
thromboxane A2 analogue U46619 (thromboxane A2 mediates adenosine fetoplacental vasoconstriction). Adenosine 
and thromboxane prostanoid receptor protein expression was determined by immunoblotting.
Results: Adenosine elicited contractions in chorionic arteries and veins which were impaired in both gestational 
diabetes mellitus and type 1 diabetes mellitus. Contractions to potassium chloride were unchanged. Adenosine A2A and 
A2B receptor protein levels were not different in gestational diabetes mellitus and normal pregnancies. Contractions 
to U46619 were unaltered in gestational diabetes mellitus arteries and increased in type 1 diabetes mellitus arteries. 
Overnight storage of vessels restored contractility to adenosine in gestational diabetes mellitus arteries and normalized 
contraction to U46619 in type 1 diabetes mellitus arteries.
Conclusion: These data are consistent with the concept of aberrant adenosine signalling in diabetes; they show for the 
first time that this involves impaired adenosine contractility of the fetoplacental vasculature.
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The human fetoplacental unit (umbilical cord and foetal 
placental vessels) is known to be devoid of nerves; there-
fore, only non-nervous mechanisms can influence vascular 
tone and blood flow in this tissue.9 Adenosine has been 
identified as one of the autacoids that is actively released 
in the foetal circulation and placental tissue of humans and 
other mammals,10–14 and there is evidence that its signal-
ling is altered in pregnancies complicated by diabetes. A 
higher adenosine concentration in venous umbilical blood, 
but not in arterial umbilical blood, was detected in preg-
nancies with GDM compared to normal pregnancies, sug-
gesting an accumulation of extracellular adenosine from 
the placenta.15 The extracellular concentration of adeno-
sine in human umbilical vein endothelial cell (HUVEC) 
cultures from GDM was also higher than in HUVECs from 
normal pregnancies, and evidence was presented that this 
involved reduced human equilibrative nucleoside trans-
porter 1 (hENT1)-mediated adenosine uptake.16–19
Very little is known about the effect of diabetes on the 
fetoplacental vasomotor response to adenosine. The only 
report to date used human umbilical vein, the largest feto-
placental vessel, and showed that endothelium-dependent 
relaxation to adenosine involving A2A receptors was 
impaired in GDM.19 Adenosine can also mediate contrac-
tion of the human placental vasculature (placental cotyle-
dons and chorionic arteries and veins) via activation of A2B 
receptors following synthesis of thromboxane A2 or a 
related metabolite and subsequent activation of prostanoid 
thromboxane prostanoid (TP) receptors.20,21 In this study, 
responses to adenosine of chorionic vessels (arteries and 
veins) from type 1 and gestational diabetes were compared 
to those of normal pregnancies. The selectivity of any 
changes was assessed by investigation of vasocontractile 
responses to a thromboxane A2 analogue, U46619, and 
smooth muscle contractility of the placental vessels was 
assessed using a receptor-independent vasoconstrictor, 
potassium chloride (KCl). Adenosine and TP receptor pro-
tein expression levels were measured using immunoblot-
ting. In light of the evidence for increased placental 
adenosine levels in maternal diabetes,15 we also sought to 
investigate whether any changes in contractility to adeno-
sine of the chorionic vessels could be recovered after an 
extended period in the absence of exposure to extracellular 
adenosine, namely, by overnight storage in physiological 
solution.
Methods
Human placenta samples
This study was based on pregnancies monitored at Queen’s 
Medical Centre (QMC), Nottingham, UK, and had the 
approval of the QMC and University Hospital NHS Trust 
Ethics Committee (Ref: 0G010101; PI-LL). The study was 
carried out in accordance with the declaration of Helsinki. 
Pregnant women with singleton pregnancy scheduled for 
elective Caesarean section were approached for written 
informed consent. The study groups included pregnant 
women who had pre-existing type 1 diabetes (T1DM), 
those diagnosed as having gestational diabetes (GDM) in 
the second trimester by either a fasting plasma glucose 
level of ⩾5.6 mmol/L or a 2-h plasma glucose level of 
⩾7.8 mmol/L22 and those who had normal, uncomplicated 
term pregnancies. Placentae were taken from elective sec-
tions only in order to avoid any parturition signals that 
may alter vascular reactivity. Pregnant women with 
asthma, smokers and pregnancies with other maternal or 
foetal conditions complicating the pregnancies (hyperten-
sion, preeclampsia and placenta praevia) were excluded.
Placentae taken were from full-term (>37 weeks) preg-
nancies. No significant difference was found in placental 
weight or birth weight between the three study groups. The 
GDM group was treated with metformin (3) or diet (4), 
while all T1DM were insulin treated. HbA1 were <6.8% 
in the diabetic groups.
Placentae (with cord clamped) were brought to the lab-
oratory within 30 min of the delivery and transferred to a 
dissecting bath with physiological salt solution (PSS), 
which had been gassed with 5% CO2 in air and adjusted to 
pH 7.4. The composition of the PSS was (mM): 127.76 
NaCl, 25 NaHCO3, 4.69 KCl, 2.4 MgSO4, 1.18 KH2PO4, 
6.05 glucose, 0.034 ethylenediaminetetraacetic acid 
(EDTA) and 1.6 CaCl2. One superficial chorionic artery 
and one chorionic vein were carefully dissected from each 
placenta. Segments were derived between first- and third-
order branches of chorionic vessels (diameter 1–2 mm). 
Two vessel ring segments (length ~0.5 cm) were obtained 
from each artery and vein from each placenta. The ring 
segments were used both as fresh tissues and after over-
night-storage. The purpose of the overnight storage was to 
determine whether an extended washout could affect aden-
osine-mediated contractility. A total of 20 human term pla-
centa from normal (n = 8), GDM (n = 7) and T1DM (n = 5) 
pregnancies were prepared for the contractility studies. 
The fresh ring segments were quickly set up in organ baths 
for contractility studies, while overnight-stored ring seg-
ments were kept at 4°C in PSS containing 2% Ficoll (type 
7000, Sigma).23
Contractility studies
Ring segments were suspended in a jacketed organ bath 
filled with PSS, gassed with 5% CO2 in air and maintained 
at 37°C. The segments were suspended between two wires 
passed through the vessel lumen. The lower wire was fixed 
to a glass supporting rod, while the upper wire was con-
nected via thread to a force transducer (Lectro-Med, 
Letchworth, UK) for isometric tension recording, linked to 
a PowerLab data acquisition unit (AD Instruments Ltd, 
Hastings, UK) via an amplifier. Segment rings were put 
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under tension of 2.0 g for 45 min equilibration, with PSS 
washout every 15 min, and allowed to relax to a resting 
tension of around 1.0–1.5 g.21,24
Segment rings were initially contracted with two to three 
60-mM KCl applications, with washout, at ~20-min inter-
vals. The last KCl response was used for analysis. After the 
final KCl application was washed out, the tissue was rested 
for 15–30 min until it reached its resting tension of 1.0–
1.5 g.21,24 Preliminary studies showed that contractile 
responses to adenosine of the chorionic vessels rapidly 
desensitize, thus cumulative concentration-response curves 
could not be carried out. Thus, adenosine was initially 
applied to the vessel segments at a concentration of 100 µM 
as this consistently produced a robust and reproducible 
response which could be used to initially assess tissue 
responsiveness to adenosine. The adenosine was rapidly 
washed out as soon as a peak contraction was reached (about 
3–5 min) and then left for 20 min before the next adenosine 
application. This was followed by the non-cumulative addi-
tion of adenosine (1 µM–1 mM) to elicit concentration-
dependent contractions of chorionic vessels21 (the order of 
adenosine applications is shown in Figure 1). Lower con-
centrations of adenosine have been reported in blood from 
human umbilical artery and vein (~0.2–0.7 µM).15 
Contractions were evoked within 3–5 min of adenosine 
applications, and once the maximal contraction was reached, 
the tissues were rapidly washed. Applications were at 
20-min intervals to minimize desensitization of the adeno-
sine-induced contraction. At the end of the experiment, 
another 30 min was allowed before the cumulative addition 
of incremental doses (1 nM–30 µM) of U46619 at 6- to 
10-min intervals.
Receptor quantification
Frozen chorionic vessel segments from GDM and normal 
groups were quantified for adenosine receptor subtypes 
(A2A, A2B and A3), and TP receptors by immunoblotting 
using standard methods.25 The antibodies used for the 
receptor quantifications were as follows: anti-A2A anti-
body (rabbit polyclonal AA 373-391, Antibodies-online.
com, 1:1000) tested positive against rat striatum, anti-A2B 
Figure 1. Representative traces showing contractions to adenosine of isolated chorionic arteries from placenta of (a) normal and 
(b) gestational diabetes (GDM) pregnancies. Adenosine was added as non-cumulative applications at concentrations of 1 µM–1 mM. 
Adenosine was washed out as soon as the contractile response had plateaued (4–5 min), and this was followed by an ~20-min 
recovery period before the next concentration was added.
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antibody (goat polyclonal sc-7505, Santa Cruz, 1:500) 
tested positive against pig bladder, anti-A3 antibody (rab-
bit polyclonal A4229, Sigma, 1:1000) tested positive 
against A3-transfected Chinese hamster ovary (CHO) cells 
and rabbit polyclonal anti-thromboxane (TBX)A2 (rabbit 
monoclonal ab134959, Abcam, 1:500) antibody tested 
positive against pig heart. Full immunoblots and positive 
controls are shown in Supplementary Figures 1–3. A2B 
receptor secondary antibody used was IRDye 800CW don-
key anti-goat polyclonal (925-32214, LI-COR). A2A and 
A3 receptor secondary antibody was goat anti-rabbit 
800CW (925-32211, LI-COR). Three different antibodies 
against the A1 receptor, from Sigma, Abcam and Alomone, 
were used but due to their lack of specificity, the samples 
were not quantified for A1 receptor expression. GAPDH 
was used (mouse monoclonal G8795, Sigma); secondary 
antibody used was IRDye 680CW goat anti-mouse (926-
68070, LI-COR).
Data quantification and statistical analysis
Contractile responses were recorded in grammes of ten-
sion. Contractile responses to adenosine and U46619 were 
expressed as a percentage of the final KCl response and 
plotted as concentration-response curves. All data are pre-
sented as mean ± standard error of mean (s.e.mean) with 
number of placentae (n). Prism software version 6.04 
(GraphPad Software, USA) was used to plot graphs and 
for statistical analysis. From concentration-response 
curves of each vessel segment, the agonist concentration 
producing 50% of the maximal response (EC50) and maxi-
mal response (Rmax) were determined. Concentration-
response curves between study groups were tested using 
two-way analysis of variance (ANOVA) followed by 
Fisher’s least significant difference (LSD) test. EC50 and 
Rmax were tested using one-way ANOVA followed by 
Fisher’s LSD test. In a few vessel segments, response 
curves to adenosine and U46619 did not plateau so Rmax 
and EC50 values could not be derived, and this accounts for 
the different n numbers in the figures and their correspond-
ing tables. Immunoblotting data were analysed using 
Student’s unpaired t-test. Significance was established by 
a p-value < 0.05.
Results
KCl contractions of chorionic vessels are similar 
in GDM and T1DM and after overnight storage
Contractile responses to KCl (60 mM) of arteries and veins 
were not significantly different between the control ves-
sels, GDM and T1DM (p > 0.05, ANOVA) (Table 1). 
Given the evidence for an accumulation of adenosine from 
the placenta,15 some vessels were stored in Krebs solution 
overnight, to determine whether this extended washout 
period affected adenosine-mediated contractility. 
Overnight storage had no significant effect on contractile 
responses to KCl of the arteries and veins of normal, GDM 
and T1DM vessels compared to their corresponding fresh 
vessels (p > 0.05, ANOVA). Thus, the contractile machin-
ery of the vascular smooth muscle of chorionic arteries and 
veins is fundamentally unimpaired by maternal diabetes.
Adenosine contractions are impaired in GDM 
arteries and veins
Adenosine (1 µM–1 mM) elicited concentration-dependent 
contractions in the chorionic arteries and veins [Figures 1, 
2(a) and 3(a)] as reported by others.21 Contractions to 
adenosine of fresh chorionic arteries from GDM were 
smaller than those of the normal arteries (p < 0.0001, 
ANOVA) [Figure 2(a)]. Contractile responses of chorionic 
veins were also smaller in freshly prepared GDM com-
pared to normal veins (p < 0.001; ANOVA) [Figure 3(a)]. 
After overnight storage, there was an increase in responses 
to adenosine in GDM arteries, and the difference in con-
tractions to adenosine between the GDM and normal arter-
ies was abolished [Figure 2(b)]. After overnight storage 
contractions to adenosine remained smaller for chorionic 
veins from GDM compared to those of the normal vessels 
(p < 0.01; ANOVA) [Figure 3(b)]. Thus, adenosine con-
tractility is impaired in chorionic arteries and veins in 
GDM, and overnight storage reverses the impaired con-
tractility in chorionic arteries, but not veins.
Adenosine contractions are impaired in T1DM 
arteries and veins
Contractions to adenosine in the chorionic arteries from 
T1DM were smaller than those of the arteries of normal 
pregnancies (p < 0.0001, ANOVA) [Figure 2(a)]. Contractile 
responses to adenosine of the chorionic veins were also 
smaller between the T1DM and normal groups (p < 0.05, 
Table 1. Contractile responses to KCl (60 mM) of chorionic 
arteries and veins from placentas of normal, gestational 
diabetes mellitus (GDM) and type 1 diabetes mellitus (T1DM) 
pregnancies. Data are expressed as mean ± s.e.mean.
Freshly collected Overnight-stored
Chorionic arteries
 Normal 0.93 ± 0.08 g (n = 8) 0.78 ± 0.09 g (n = 6)
 GDM 1.46 ± 0.22 g (n = 7) 0.99 ± 0.14 g (n = 7)
 T1DM 1.00 ± 0.19 g (n = 5) 1.16 ± 0.21 g (n = 5)
Chorionic veins
 Normal 1.28 ± 0.19 g (n = 8) 1.40 ± 0.22 g (n = 6)
 GDM 1.51 ± 0.20 g (n = 7) 1.33 ± 0.23 g (n = 7)
 T1DM 1.84 ± 0.44 g (n = 5) 1.48 ± 0.38 g (n = 5)
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ANOVA) [Figure 3(a)]. After overnight storage, the signifi-
cant difference in contractions to adenosine between the 
T1DM and normal arteries was still apparent (p < 0.05, 
ANOVA) [Figure 2(b)]. After overnight storage, the 
responses to adenosine remained smaller in T1DM com-
pared to normal veins, although not significantly so (p > 0.05, 
ANOVA) [Figure 3(b)]. Thus, contractile responses to aden-
osine are impaired in both chorionic arteries and veins in 
T1DM, and this is not fundamentally altered by overnight 
storage.
Effect of GDM on vasocontractile responses to 
U46619
U46619 (1–300 nM) elicited concentration-dependent 
contractions in the chorionic arteries and veins (Figures 4 
and 5). Contractile responses to U46619 were similar 
between GDM and normal groups in the arteries [Figure 
4(a)] (p > 0.05, ANOVA) and were reduced in the GDM 
veins (p < 0.0001, ANOVA) [Figure 5(a)]. After overnight 
storage, responses to U46619 in the chorionic arteries 
(normal and GDM) were increased overall [see Figure 4(a) 
and (b)]. However, the responses to U46619 in the arteries 
between GDM and normal groups remained similar 
[Figure 4(b)] (p > 0.05, ANOVA). After overnight storage, 
contractile responses to U46619 in chorionic veins also 
remained smaller compared to the normal veins (p < 0.01, 
ANOVA) [Figure 5(b)].
U46619 contractions are augmented in T1DM 
arteries and veins
Contractile responses to U46619 of the chorionic arteries 
were larger in the T1DM group compared to normal and 
GDM (p < 0.0001, ANOVA) with a significantly greater 
Rmax in the T1DM group compared to the normal and GDM 
groups (p < 0.05, ANOVA) [Figure 4(a)]. Contractile 
responses to U46619 in chorionic veins were also greater 
in T1DM compared to the normal group (p < 0.01, 
ANOVA) [Figure 5(a)]. Overnight storage normalized the 
Figure 2. Response to adenosine in (a) fresh and (b) overnight-stored chorionic arteries from gestational diabetes mellitus (GDM), 
type 1 diabetes mellitus (T1DM) and normal pregnancies. Table indicates potencies (EC50) and maximum response to adenosine 
(Rmax). Values are mean ± s.e.mean with the number of placentae (n) shown in parentheses. % of contraction compared to potassium 
chloride (KCl, 60 mM).
*p < 0.05; ****p < 0.0001 compared to normal; ϕp < 0.05 compared to GDM, two-way ANOVA; ^p < 0.01 compared to normal, one-way ANOVA.
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differences in the responses between the normal and 
T1DM chorionic arteries, such that responses to U46619 
were no longer significantly different between the two 
groups (p > 0.05, ANOVA) [Figure 4(b)]. After overnight 
storage, the responses to U46619 were slightly reduced in 
the veins in T1DM compared to the normal group 
(p < 0.001, ANOVA) [Figure 5(b)].
Immunoblotting for receptor quantification in 
normal and GDM vessels
Expression levels of A2A, A2B and A3 receptor protein were 
investigated using immunoblotting in normal and GDM 
arteries and veins. A1 receptor protein was not investigated 
as we could not demonstrate specificity of the antibodies. 
Bands were seen at ~45 kDa for the A2A receptor protein 
and ~50 kDa for the A2B receptor protein, which is similar 
to their predicted molecular weights of 45 kDa (Figure 6). 
The band size of the A3 receptor protein was ~50 kDa in 
both chorionic arteries and veins, which is greater than its 
predicted molecular weight of 36 kDa. There was no sig-
nificant difference between normal and GDM arteries and 
veins with regard to expression of A2A and A2B receptor 
protein (Figure 6). A3 receptor protein expression was sim-
ilar in normal and GDM arteries, but was lower in veins of 
GDM compared to normal pregnancies (p < 0.05, Student’s 
t-test) (Figure 6). Immunostaining for the TP receptor pro-
tein was observed at ~50 kDa, which is similar to its pre-
dicted molecular weight of 44 kDa. TP receptor protein 
expression was lower in GDM arteries compared to nor-
mal arteries (p < 0.05, Student’s t-test) [Figure 7(a)], but 
expression levels were similar in normal and GDM veins 
[Figure 7(b)].
Discussion
This is the first study to investigate responses to adenosine 
in human chorionic vessels from pregnancies complicated 
Figure 3. Response to adenosine in (a) fresh and (b) overnight-stored chorionic veins from gestational diabetes mellitus (GDM), 
type 1 diabetes mellitus (T1DM) and normal pregnancies. Table indicates potencies (EC50) and maximum response to adenosine 
(Rmax). Values are mean ± s.e.mean for number of placentae (n) shown in parentheses. % of contraction compared to potassium 
chloride (KCl, 60 mM).
*p < 0.05; **p < 0.01; ***p < 0.001 compared to normal, two-way ANOVA.
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by two types of maternal diabetes, GDM and T1DM. The 
main finding in this study is that there is an impaired con-
tractile response to adenosine in chorionic arteries and 
veins isolated from pregnancies with GDM and T1DM 
compared to vessels from normal pregnancies. Contraction 
to adenosine of human chorionic arteries and veins is 
mediated by A2B receptors and a release of thromboxane 
A2 or a related metabolite.21 Here, we show that in chori-
onic arteries of both GDM and T1DM, the impaired aden-
osine contraction does not involve impaired signalling via 
TP receptors.
This study provides further evidence that adenosine 
induces vasoconstriction in human-isolated chorionic ves-
sels and cotyledons.20,21,26 Both the potency and maximal 
responses to adenosine in chorionic arteries and veins from 
normal pregnancies (artery EC50 10 µM, Rmax 51%; vein 
EC50 29 µM, Rmax 42%) are similar to those obtained by 
Donoso and colleagues (artery EC50 38 µM, Rmax 43%; vein 
EC50 38 µM, Rmax 41%).21 Others have reported relaxation 
of the human fetoplacental vasculature to adenosine, but 
either at substantially higher concentrations (EC50 ~1 mM 
adenosine) in isolated chorionic vessels27 or as a slow 
response (developed over 20–30 min) in perfused cotyle-
dons.28 Biphasic responses of human isolated chorionic 
vessels to adenosine, with initial contraction (within 4 min) 
followed by relaxation (within 10–15 min), were also 
reported,26 and similarly in the ovine placental vascula-
ture.29 The human placental vasculature expresses all four 
adenosine receptors, A1, A2A, A2B and A3.21,30,31 The con-
tractile adenosine receptor in human chorionic arteries and 
veins has been characterized as the A2B subtype, located 
largely on the endothelium, which activates the cyclooxy-
genase pathway to mediate synthesis of thromboxane A2 or 
a related metabolite, whereas the relaxation appears to 
involve smooth muscle A2/A3 receptors.21,28 In vivo, the 
vascular responses are likely to depend on the adenosine 
levels, and endothelial integrity, such that an acute increase 
in adenosine will cause predominantly vasoconstriction, 
Figure 4. Response to U46619 in (a) fresh and (b) overnight-stored chorionic arteries from gestational diabetes mellitus (GDM), 
type 1 diabetes mellitus (T1DM) and normal pregnancies. Table indicates potencies (EC50) and maximum response to U46619 
(Rmax). Values are mean ± s.e.mean for the number of placentae (n) shown in parentheses. % of contraction compared to potassium 
chloride (KCl, 60 mM).
****p < 0.0001 compared to normal, two-way ANOVA; ^p < 0.05 compared to normal; ψp < 0.05 compared to GDM, one-way ANOVA.
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whereas a sustained increase in adenosine will elicit addi-
tionally/predominantly relaxation, and this will help with 
the regional distribution of blood; an overall increase in the 
placental concentration of adenosine would, therefore, be 
expected to dampen adenosine-mediated blood flow regu-
lation if accompanied by significant adenosine receptor 
desensitization.
Here, we report, for the first time, impaired contractions 
to adenosine of chorionic vessels (arteries and veins) from 
both GDM and T1DM, suggesting a systemic alteration of 
adenosine signalling in the fetoplacental circulation in 
maternal diabetes. This did not involve a generalized impair-
ment of contractility of the vascular smooth muscle since 
responses to KCl, a receptor-independent vasoconstrictor, 
were similar between the normal and diabetic groups. 
Moreover, the impaired responsiveness to adenosine in cho-
rionic arteries was selective with respect to responses to 
U46619, which were unaltered in GDM and increased in 
T1DM chorionic arteries. Selective impairment of the 
response to adenosine was also observed in chorionic veins 
from T1DM, since U46619 mediated responses were aug-
mented. In GDM, veins impaired responsiveness to U46619 
accompanied the impaired contractile response to adeno-
sine. Adenosine contractions involve the production and 
actions of thromboxane A2,21 but these data suggest that 
impaired adenosine contractions in artery and vein in 
T1DM, and in artery in GDM, do not involve defective sig-
nalling via TP receptors.
We used immunoblotting to investigate whether altered 
adenosine receptor expression could underlie the impaired 
contractile responses of the chorionic arteries and veins from 
GDM. There is a precedent for changes in placental adeno-
sine receptor expression in complicated pregnancies since, in 
preeclampsia, the protein and messenger RNA (mRNA) of 
all four adenosine receptors were increased in placental biop-
sies and villous explants.31 The band sizes of ~45 kDa for the 
A2A receptor protein and ~50 kDa for the A2B receptor pro-
tein are similar to their predicted molecular weights of 45 
Figure 5. Response to U46619 in (a) fresh and (b) overnight-stored chorionic veins from gestational diabetes mellitus (GDM), 
type 1 diabetes mellitus (T1DM) and normal pregnancies. Table indicates potencies (EC50) and maximum response to U46619 
(Rmax). Values are mean ± s.e.mean for the number of placentae (n) shown in parentheses. % of contraction compared to potassium 
chloride (KCl, 60 mM).
**p < 0.01; ***p < 0.001; ****p < 0.0001 compared to normal, two-way ANOVA.
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kDa, and to the bands observed in human placental biopsies 
(45 kDa, A2A; 52 kDa, A2B).31 The band size of the A3 recep-
tor protein at ~50 kDa in both chorionic arteries and veins is 
greater than its predicted molecular weight of 36 kDa. 
Immunostaining for the A3 receptor protein in human placen-
tal biopsies31 showed a band of ~36 kDa and an additional 
higher molecular weight band which could correspond to our 
band of ~50 kDa. We found no difference in A2B (and A2A) 
Figure 6. Expression levels of A2A (~45 kDa) (a, b), A2B (~50 kDa) (c, d) and A3 (~50 kDa) (e, f) adenosine receptor proteins 
in chorionic arteries (a, c, e) and chorionic veins (b, d, f) from term placenta of normal and gestational diabetic mellitus (GDM) 
pregnancies. Blots show bands for adenosine receptor proteins (green) and GAPDH (~36 kDa) (red). Data are expressed as the 
ratio of A2A to GAPDH band intensities and are the mean ± s.e.mean of five normal and five GDM samples.
*p < 0.05, Student’s t-test.
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adenosine receptor protein expression levels between GDM 
and normal chorionic arteries and veins. It is possible that the 
impaired contractility to adenosine in GDM (and possibly 
T1DM) involves A2B receptor desensitization/internaliza-
tion,32 perhaps as a consequence increased extracellular lev-
els of adenosine in the GDM placenta.15 Rapid fade of 
contractile responses to P2Y1 receptor activation in human 
chorionic arteries was attributed to its exit from membrane 
lipid rafts and internalization.33 In contrast, contractile 
responses of the human chorionic vasculature to U46619 and 
PGF2α are sustained.34–36 A limitation of our study is that we 
do not have data for receptor protein expression in chorionic 
vessels from T1DM, but the data with GDM show that 
changes in agonist-induced contractile function can occur 
without a change in the level of receptor protein.
Whether the impaired contractility to adenosine in cho-
rionic vessels from GDM and T1DM involves changes in 
plasma glucose concentrations is unclear. Maternal hyper-
glycaemia induces foetal hyperglycaemia and subsequent 
changes in the foetal circulation such as lower oxygen con-
tent and saturation.37 However, hypoxia has been shown to 
increase mRNA expression of the trophoblast A2B receptor 
(which was shown to mediate proliferation, invasion and 
activation of cAMP response element binding protein).38 A 
high glucose concentration impairs vascular endothelial 
function in vitro,39 and since endothelium removal 
attenuates adenosine-mediated contractions in chorionic 
vessels,21 this could contribute to the aberrant adenosine-
mediated contractions in maternal diabetes. However, the 
blood glucose levels of the volunteers in our study are 
likely to have been well controlled, and others have 
reported no change in glucose in umbilical vein blood 
from normal and gestational diabetic pregnancies.17 There 
is evidence that insulin receptors regulate placental vascu-
lar adenosine transport and nitric oxide generation,15,19,40 
and investigation of the impact of this in the study groups 
is an important avenue for future investigation.
Overnight storage in physiological solution reversed 
some of the changes, restoring contractility to adenosine in 
the GDM chorionic arteries. This recovery of function 
may involve resensitization/upregulation of contractile 
A2B receptors due to the removal of locally released or cir-
culating adenosine. Extracellular levels of adenosine in the 
placental circulation may be elevated in maternal 
diabetes, an effect involving downregulation of placental 
hENT1,15–17 and this may contribute to the reduced adeno-
sine responses. An important limitation of this study is that 
adenosine levels were not measured in the tissue/blood so 
we do not have evidence that the differences that we have 
observed are a consequence of changes in adenosine lev-
els. Changes in adenosine and adenosine triphosphate 
(ATP) release and metabolism could also be important in 
local elevations in placental vascular adenosine concentra-
tion.41 KCl contractions were unaffected by overnight stor-
age, suggesting that the recovery of function involved 
specific changes relevant to adenosine signalling. Reduced 
responses to KCl after overnight storage have reported by 
others,42 but we did not see this. Overnight storage did not, 
however, reverse impaired contractility to adenosine in 
GDM chorionic veins, or in T1DM chorionic arteries and 
veins, suggesting more complex changes in contractility.
Contraction to U46619 in GDM arteries was unchanged, 
and in veins it was modestly reduced. This did not corre-
late with changes in TP receptor protein levels which were 
reduced in arteries and unchanged in veins. Interestingly, 
contractile responses to U46619 were much larger in nor-
mal veins than in arteries (Rmax 198% veins; Rmax 119% 
Figure 7. TP receptor protein (TBXA2 ~50 kDa) and 
GAPDH (~36 kDa) expression levels in (a) chorionic arteries 
and (b) chorionic veins. Ratio of expression levels of TBXA2 
to GAPDH in chorionic arteries (a) and chorionic veins (b) 
from term placenta of normal and gestational diabetic mellitus 
(GDM) pregnancies based on the intensities of the bands. Data 
are expressed as the ratio of TBXA2 protein to GAPDH band 
intensities and are the mean ± s.e.mean of five samples.
*p < 0.05, Student’s t-test.
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arteries), which correlates with the greater (approximately 
10-fold) TP receptor expression in the veins. Contraction 
to U46619 was enhanced in chorionic vessels from T1DM, 
in both arteries and veins, and this was reversed by over-
night storage. In contrast, impaired vasoconstrictor 
responses to U46619 of perfused cotyledons from women 
with pregestational diabetes has been reported, attributed 
to a reduction in the affinity but not the number of placen-
tal TP receptors; placental thromboxane production was 
unchanged.43 The reason for the increase in U46619 
responses observed in this study in T1DM arteries and 
veins, but not in GDM vessels, is unclear. However, it is 
possible that the opposite changes in responses to adeno-
sine and U46619 in T1DM vessels reflect a compensatory 
mechanism as placental vasoactive autacoids are known to 
work in concert to ensure optimum placental haemody-
namic function in vivo.
Despite the evidence for a vasocontractile role of aden-
osine in the human placental vasculature,20,21 there is an 
emphasis in the literature on adenosine-mediated placental 
vasorelaxation, possibly because adenosine is a vasodila-
tor in most other vascular beds.44 This study reinforces that 
overall control of fetoplacental haemodynamics by adeno-
sine will involve the coordinated actions of vasocontractile 
as well as vasodilator adenosine receptors, likely differ-
ently expressed throughout the placental vascular tree as 
shown for the purine nucleotide receptors P2Y1 and 
P2Y2.45 The impaired adenosine-mediated contractility of 
chorionic vessels in maternal diabetes reported in this 
study might lead to a shift in balance towards adenosine-
mediated placental vasorelaxation, although evidence for 
impaired adenosine relaxation in the umbilical vein in 
GDM,19 suggests that adenosine-mediated blood flow reg-
ulation overall may be dampened.
Conclusion
This study reaffirms the presence of adenosine-induced 
vasocontraction in human chorionic vessels. The study has 
provided the first evidence of an altered contractile 
response to adenosine in chorionic vessels from pregnan-
cies complicated by both pregestational and gestational 
diabetes. Impaired responses to adenosine in both chori-
onic arteries and veins suggest a systemic alteration of 
adenosine signalling in the fetoplacental circulation which 
may be contributed by both foetus and placenta in response 
to the maternal diabetes, and which may involve desensiti-
zation/downregulation of adenosine receptors. Our study 
contributes to a better understanding of differential func-
tion of the vasculature in diabetes.
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